or Try an Advanced Search...

    ETF Components for WDNA - WisdomTree BioRevolution Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TWST C 1.44 3.94
    BPMC B -1.21 2.74
    LLY B -0.95 2.53
    NTRA B 0.85 2.49
    GERN C 4.56 2.47
    AGIO C -0.07 2.31
    VCEL D -0.36 2.02
    SRPT C -0.71 1.99
    BBIO D 0.36 1.63
    VRTX B -0.74 1.61
    IOVA F -4.40 1.58
    UTHR B -1.90 1.52
    REGN B -1.97 1.51
    ALNY A 0.43 1.47
    IONS B 1.02 1.45
    FATE F -1.86 1.44
    AMGN B -0.45 1.43
    DHR D -0.17 1.40
    CTLT B 0.55 1.38
    MYGN B 0.77 1.38
    NVS A 0.32 1.37
    CRSP F 1.48 1.34
    DD B -0.21 1.34
    MRK C -1.46 1.28
    STOK D -1.25 1.26
    RARE F -1.83 1.23
    AZN C -0.25 1.22
    FOLD F -0.41 1.21
    VCYT C 0.99 1.19
    DOW D 0.32 1.18
    ZTS C 0.45 1.18
    TSN D -1.08 1.17
    TMO D 0.31 1.17
    ARCT F 2.09 1.14
    DAR D -0.65 1.11
    A D 0.28 1.11
    JNJ F -0.23 1.08
    QGEN D -0.29 1.08
    NEO D 0.00 1.07
    CTVA D -0.55 1.07
    GMAB F 1.00 1.06
    BEAM D 4.03 1.06
    ARWR C -0.59 1.04
    GILD C -2.65 0.98
    TECH D 0.29 0.98
    BIIB C -1.84 0.96
    BMRN D -1.51 0.95
    MRNA D -0.96 0.90
    RGEN F 0.52 0.90
    BMY F -0.96 0.89
    ADM C 0.90 0.89
    PFE D -0.47 0.88
    ILMN F -0.22 0.84
    EDIT F 2.64 0.83
    BNTX F 1.40 0.80
    RGNX F 0.65 0.79
    EXAS F 0.05 0.79
    BIO F 0.94 0.74
    SDGR F -1.13 0.74
    NTLA F 3.61 0.73
    GPRE F -0.92 0.70
    FMC F 0.07 0.67
    BYND F -1.30 0.65
    SANA F -2.43 0.61
    ALLO F -3.70 0.55
    ORGN F 0.26 0.49
    TXG F -0.64 0.44
    VERV F 2.80 0.44
    CRBU F 0.00 0.43
    CVAC F -6.59 0.43
    PGEN C -1.34 0.41
    DNA F 8.37 0.33
    ABSI F 7.07 0.21
    PACB F 1.56 0.15

    Represented by ETF Holdings

    Keywords: Biotechnology S&P 500 Biopharmaceutical Life Sciences Medicine Biology Cancer Acid Genetics Lab Testing Nasdaq 100 Cholesterol Disease Infectious Diseases Molecular Biology Pharmaceutical Products Amyloid Animal Health Clinical Medicine Drug Discovery
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Chemicals Agricultural Inputs Drug Manufacturers - Specialty & Generic Farm Products Health Information Services Health Information Services Long-Term Care Facilities Packaged Foods Specialty Chemicals Waste Management

    Recent News for WisdomTree BioRevolution Fund & its Holdings

    Date Stock Title
    Jul 3 ABSI Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Jul 3 TECH 'Breaking Up Google Would Drive 10%-15% Upside' For Shareholders, Analyst Says
    Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
    Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
    Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 TSN Sizzling Prices: July 4th barbecue will cost more this year than any other
    Jul 3 ADM Sizzling Prices: July 4th barbecue will cost more this year than any other
    Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 BYND Do US fast-food customers want plant-based meat? Panda Express thinks so, but McDonald's has doubts
    Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
    Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
    Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
    Jul 3 TECH Tesla Stock Soars On Q2 Delivery Beat: Chart Signals Strong Bullish Momentum
    Jul 3 MRK Merck: Among The Best Health Care GARP Plays Today
    Jul 3 ABSI Morgan Stanley starts Absci at overweight, cites AI theme
    Jul 3 CVAC GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
    The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (?index?). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
    Back to the Main WDNA Page...